United States Renal Data System.USRDS 2006 Annual Data Report: Atlas of End-Stage Renal Disease in the United States.Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2006.
2.
PaniaguaR., AmatoD., VoneshE., Correa-RotterR., RamosA., MoranJ.; Mexican Nephrology Collaborative Study Group. Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial.J Am Soc Nephrol2002; 13: 1307–20.
3.
LoW.K., HoY.W., LiC.S., WongK.S., ChanT.M., YuA.W.Effect of Kt/V on survival and clinical outcome in CAPD patients in a randomized prospective study.Kidney Int2003; 64: 649–56.
4.
KoningsC.J., KoomanJ.P., SchonckM., Cox-ReijvenP.L., van KreelB., GladziwaU.Assessment of fluid status in peritoneal dialysis patients.Perit Dial Int2002; 22: 683–92.
5.
OeB., de FijterC.W., GeersT.B., VosP.F., DonkerA.J., de VriesP.M.Diameter of inferior caval vein and impedance analysis for assessment of hydration status in peritoneal dialysis.Artif Organs2000; 24: 575–7.
6.
CocchiR., Degli EspostiE., FabbriA., LucatelloA., SturaniA., QuarelloF.Prevalence of hypertension in patients on peritoneal dialysis: results of an Italian multicentre study.Nephrol Dial Transplant1999; 14: 1536–40.
7.
VelasquezM.T., LewS.Q., von AlbertiniB., MishkinG.J., BoschJ.P.Control of hypertension is better during hemodialysis than during continuous ambulatory peritoneal dialysis in ESRD patients.Clin Nephrol1997; 48: 341–5.
8.
PlumJ., SchoenickeG., KleophasW., KulasW., SteffensF., AzemA.Comparison of body fluid distribution between chronic haemodialysis and peritoneal dialysis patients as assessed by biophysical and biochemical methods.Nephrol Dial Transplant2001; 16: 2378–85.
9.
FrankenfieldD.L., ProwantB.F., FlaniganM.J., FrederickP.R., BailieG.R., HelgersonS.D.Trends in clinical indicators of care for adult peritoneal dialysis patients in the United States from 1995 to 1997. ESRD Core Indicators Workgroup.Kidney Int1999; 55: 1998–2010.
10.
TakedaK., NakamotoM., HirakataH., BabaM., KuboM., FujishimaM.Disadvantage of long-term CAPD for preserving cardiac performance: an echocardiographic study.Am J Kidney Dis1998; 32: 482–7.
11.
FallerB., LameireN.Evolution of clinical parameters and peritoneal function in a cohort of CAPD patients followed over 7 years.Nephrol Dial Transplant1994; 9: 280–6.
12.
EniaG., MallamaciF., BenedettoF.A., PanuccioV., ParlongoS., CutrupiS.Long-term CAPD patients are volume expanded and display more severe left ventricular hypertrophy than haemodialysis patients.Nephrol Dial Transplant2001; 16: 1459–64.
13.
KoningsC.J., KoomanJ.P., SchonckM., StruijkD.G., GladziwaU., HoorntjeS.J.Fluid status in CAPD patients is related to peritoneal transport and residual renal function: evidence from a longitudinal study.Nephrol Dial Transplant2003; 18: 797–803.
14.
Tzamalouk asA.H., SaddlerM.C., MurataG.H., MalhotraD., SenaP., SimonD.Symptomatic fluid retention in patients on continuous peritoneal dialysis.J Am Soc Nephrol1995; 6: 198–206.
15.
NakayamaM., KawaguchiY.; Water and Electrolyte Balance (WEB) Study Group in CAPD. Multicenter survey on hydration status and control of blood pressure in Japanese CAPD patients.Perit Dial Int2002; 22: 411–14.
16.
WongP.N., MakS.K., LoK.Y., TongG.M., WongA.K.Factors associated with poorly controlled hypertension in continuous ambulatory peritoneal dialysis patients.Singapore Med J2004; 45: 520–4.
17.
KocM., ToprakA., TezcanH., BihoracA., AkogluE., OzenerI.C.Uncontrolled hypertension due to volume overload contributes to higher left ventricular mass index in CAPD patients.Nephrol Dial Transplant2002; 17: 1661–6.
18.
GanH.B., ChenM.H., LindholmB., WangT.Volume control in diabetic and nondiabetic peritoneal dialysis patients.Int Urol Nephrol2005; 37: 575–9.
19.
WoodrowG., OldroydB., StablesG., GibsonJ., TurneyJ.H., BrownjohnA.M.Effects of icodextrin in automated peritoneal dialysis on blood pressure and bioelectrical impedance analysis.Nephrol Dial Transplant2000; 15: 862–6.
20.
JonesC.H., WellsL., StovesJ., FarquharF., WoodrowG.Can a reduction in extracellular fluid volume result in increased serum albumin in peritoneal dialysis patients?Am J Kidney Dis2002; 39: 872–5.
21.
TonbulZ., AltintepeL., SozluC., YeksanM., YildizA., TurkS.The association of peritoneal transport properties with 24-hour blood pressure levels in CAPD patients.Perit Dial Int2003; 23: 46–52.
22.
GunalA.I., DumanS., OzkahyaM., TozH., AsciG., AkcicekF.Strict volume control normalizes hypertension in peritoneal dialysis patients.Am J Kidney Dis2001; 37: 588–93.
23.
KawanishiH., HashimotoY., NakamotoH., NakayamaM., TranaeusA.Combination therapy with peritoneal dialysis and hemodialysis.Perit Dial Int2006; 26: 150–4.
24.
KoningsC.J., KoomanJ.P., SchonckM., DammersR., CheriexE., Palmans MeulemansA.P.Fluid status, blood pressure, and cardiovascular abnormalities in patients on peritoneal dialysis.Perit Dial Int2002; 22: 477–87.
25.
KoningsC.J., KoomanJ.P., SchonckM., GladziwaU., WirtzJ., van den Wall BakeA.W.Effect of icodextrin on volume status, blood pressure and echocardiographic parameters: a randomized study.Kidney Int2003; 63: 1556–63.
26.
FoleyR.N., ParfreyP.S., HarnettJ.D., KentG.M., MartinC.J., MurrayD.C.Clinical and echocardiographic disease in patients starting end-stage renal disease therapy.Kidney Int1995; 47: 186–92.
27.
AtesK., NergizogluG., KevenK., SenA., KutlayS., ErturkS.Effect of fluid and sodium removal on mortality in peritoneal dialysis patients.Kidney Int2001; 60: 767–76.
28.
SmitW., StruijkD.G., Ho-dac-PannekeetM.M., KredietR.T.Quantification of free water transport in peritoneal dialysis.Kidney Int2004; 66: 849–54.
29.
ParikovaA., SmitW., StruijkD.G., ZweersM.M., KredietR.T.The contribution of free water transport and small pore transport to the total fluid removal in peritoneal dialysis.Kidney Int2005; 68: 1849–56.
Rodriguez-CarmonaA., FontanM.P.Sodium removal in patients undergoing CAPD and automated peritoneal dialysis.Perit Dial Int2002; 22: 705–13.
32.
Rodriguez-CarmonaA., Perez-FontanM., Garca-NaveiroR., VillaverdeP., PeteiroJ.Compared time profiles of ultrafiltration, sodium removal, and renal function in incident CAPD and automated peritoneal dialysis patients.Am J Kidney Dis2004; 44: 132–45.
33.
BavbekN., AkayH., AltayM., UzE., TurgutF., UyarM.E.Serum BNP concentration and left ventricular mass in CAPD and automated peritoneal dialysis patients.Perit Dial Int2007; 27: 663–8.
34.
LeeJ.A., KimD.H., YooS.J., OhD.J., YuS.H., KangE.T.Association between serum N-terminal pro-brain natriuretic pep-tide concentration and left ventricular dysfunction and extracellular water in continuous ambulatory peritoneal dialysis patients.Perit Dial Int2006; 26: 360–5.
35.
de FijterC.W., OeL.P., NautaJ.J., van der MeulenJ., VerbrughH.A., VerhoefJ.Clinical efficacy and morbidity associated with continuous cyclic compared with continuous ambulatory peritoneal dialysis.Ann Intern Med1994; 120: 264–71.
36.
BroS., BjornerJ.B., Tofte-JensenP., KlemS., AlmtoftB., DanielsenH.A prospective, randomized multicenter study comparing APD and CAPD treatment.Perit Dial Int1999; 19: 526–33.